The federal government announced Tuesday it is investing $67.5 million into a “personalized medicine” health care strategy that will factor in a patient's genetics and the specific character of their illness before customizing a treatment plan.
Read the original:
Feds invest $67.5M into 'personalized medicine'
18-01-2012 03:45 Tonight on the Tuesday, January 17, 2012 edition of the Infowars Nightly News: • Alex interviews Infowars contributing writer and vaccine researcher Curt Linderman Sr. about the medical tyranny hoax that ceaseless continues in trying to trick the public into complying with “mandatory” vaccinations. In the latest episode, a Pennsylvanian doctor reported her patient to a state trooper, as well as Children and Youth Services Department, after the mother, Rachel Garmon, refused dangerous inoculations for her son.
Original post:
Medical Tyranny: Infowars Nightly News – Video
(Reuters) – Celebrity chef Paula Deen, best known for her high-calorie Southern cooking featured in cookbooks and on popular Food Network shows, confirmed on Tuesday she has Type 2 diabetes. Speaking on NBC's “Today” show, Deen, who turns 65 on Thursday, said she found out three years ago during a routine physical exam that she had the disease. “I'm here today to let the world know that it is …
See the article here:
Celebrity chef Deen says she has diabetes
SALT LAKE CITY — Myriad Genetics, Inc. today announced that it will issue financial results for the second fiscal quarter following the close of market on Tuesday, January 31, 2012.
More here:
Myriad Genetics to Announce Fiscal 2012 Second Quarter Results on Tuesday, January 31, 2012
Britain said Tuesday it had signed deals with China to research stem cells and smart grids, after Chancellor of the Exchequer George Osborne held talks with officials in Beijing aimed at attracting investment.
Original post:
Britain announces research deals with China
Nick Cannon is speaking out for the first time since his recent kidney ordeal, saying he's back to his old self. The “The America's Got Talent” host spoke out about his recent health scare on Howard Stern's SiriusXM radio show on Tuesday morning.
Original post:
Nick Cannon: I'm 'Good' After Kidney Health Scare
The government said Tuesday it had signed deals with China to research stem cells and smart grids, after finance minister George Osborne held talks with officials in Beijing aimed at attracting investment.
Read the original post:
Govt announces research deals with China
TEL AVIV (Reuters) – Data from the first ALS patients in a clinical trial treated with BrainStorm Cell Therapeutics adult stem cell therapy did not show significant side effects and the treatment has so far proven to be safe, the company said on Tuesday. Israel-based BrainStorm is developing NurOwn for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, a …
Continued here:
BrainStorm sees positive data in ALS stem cell trial
NEW YORK – After years of predictions that the '$1,000 genome' – a read-out of a person's complete genetic information for about the cost of a dental crown – was just around the corner, a US company is announcing Tuesday that it has achieved that milestone and taken the technology several steps ahead.
See the original post:
New genome reader to bring promise, perils of genetics to clinics
Stem cells from cord blood “re-educated” the immune system T cells of people with type 1 diabetes so their pancreas started producing insulin again, thereby reducing the amount of insulin they needed to inject. These are the findings of a study led by Dr Yong Zhao, from University of Illinois at Chicago that were published online on Tuesday in the open access journal BMC Medicine. Type 1 …
Read more here:
Type 1 Diabetes Reversed With Stem Cells From Cord Blood
NEW YORK (Reuters) – After years of predictions that the “$1,000 genome” – a read-out of a person’s complete genetic information for about the cost of a dental crown – was just around the corner, a U.S.
Visit link:
Insight: New DNA reader to bring promise
NEW YORK – After years of predictions that the “$1,000 genome” – a read-out of a person’s complete genetic information for about the cost of a dental crown – was just around the corner, a US company is announcing Tuesday that it has achieved that milestone and taken the technology several steps ahead.
See original here:
New DNA reader to bring promise
NEW YORK (Reuters) – New DNA reader could bring genetics to medical clinics.
Read more from the original source:
New DNA reader to bring promise, perils of genetics to clinics
A bill to provide for the establishment of a Regional Centre for Biotechnology for training and education as an institution of national importance was tabled in the Lok Sabha on Tuesday. …
Excerpt from:
Biotechnology Bill introduced in LS
(Reuters) – U.S. health regulators have accepted the application for Pfizer Inc’s closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday. The Food and Drug Administration is due to decide on the drug, tofacitinib, in August
Boris the dog has arthritis.
KUALA LUMPUR, Dec 13 (Bernama) — Fifteen per cent or 4.2 million of the Malaysian population are at risk of chronic kidney disease (CKD), Director-General of Health Datuk Seri Dr Hassan Abdul Rahman said Tuesday.
Visit link:
15 Per Cent Of Malaysians At Risk Of Chronic Kidney Disease – Health Director General
Baxter International Inc.
See original here:
Baxter buys regenerative medicine firm for $325M
NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has begun testing the waters of clinical sequencing, and five of the grants it announced Tuesday as part of its revamped Genome Sequencing Program mark its first steps toward pursuing DNA sequencing in the clinic.
Read the original post:
New NHGRI Projects Seek to Further Sequencing-based Medicine
British researchers claim to have created stem cells of a “gold standard” quality that could lead to a new wave of treatments for degenerative diseases. Taken from human embryos, they could be available to researchers before the end of next year for eventual use in clinical trials, The Daily Telegraph reported Tuesday.
Go here to see the original:
“Gold standard” stem cells for clinical testing